Literature DB >> 16244192

Release of alpha-actin into serum after skeletal muscle damage.

A Martínez-Amat1, H Boulaiz, J Prados, J A Marchal, P Padial Puche, O Caba, F Rodríguez-Serrano, A Aránega.   

Abstract

OBJECTIVE: The skeletal muscle protein alpha-actin was investigated in the serum of subjects with severe skeletal muscle damage to assess its utility as a reliable and predictive marker of muscle damage.
METHODS: Serum samples were obtained from 33 healthy controls and 33 patients with severe skeletal muscle damage, defined by a total creatine kinase value of >500 IU/l (Rosalki method). Troponin I, troponin T, and myoglobin concentrations were determined by immunoassay and alpha-actin concentrations by Western blot and densitometry.
RESULTS: The mean serum concentration of alpha-actin in controls and patients with skeletal muscle damage was 600.9 and 1968.51 ng/ml, respectively, a statistically significant difference. Sera of patients with muscle damage showed higher levels of alpha-actin than of troponin or myoglobin. No significant difference in troponin I levels was observed between the groups.
CONCLUSIONS: According to these results, alpha-actin was the most significant skeletal muscle damage marker analysed and may be an ideal candidate for the identification of all types of myofibre injury, including sports injuries. Our findings support the use of alpha-actin as a marker alongside other currently used biological proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16244192      PMCID: PMC1725075          DOI: 10.1136/bjsm.2004.017566

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN: 0306-3674            Impact factor:   13.800


  32 in total

Review 1.  Overtraining and recovery. A conceptual model.

Authors:  G Kenttä; P Hassmén
Journal:  Sports Med       Date:  1998-07       Impact factor: 11.136

2.  Eccentric exercise decreases maximal insulin action in humans: muscle and systemic effects.

Authors:  S Asp; J R Daugaard; S Kristiansen; B Kiens; E A Richter
Journal:  J Physiol       Date:  1996-08-01       Impact factor: 5.182

3.  Modulation of alpha-actin and alpha-actinin proteins in cardiomyocytes by retinoic acid during development.

Authors:  A E Aránega; C Velez; J Prados; C Melguizo; J A Marchal; N Arena; L Alvarez; A Aránega
Journal:  Cells Tissues Organs       Date:  1999       Impact factor: 2.481

4.  Relations between muscle soreness and biochemical and functional outcomes of eccentric exercise.

Authors:  J B Rodenburg; P R Bär; R W De Boer
Journal:  J Appl Physiol (1985)       Date:  1993-06

5.  Skeletal troponin I as a marker of exercise-induced muscle damage.

Authors:  S Sorichter; J Mair; A Koller; W Gebert; D Rama; C Calzolari; E Artner-Dworzak; B Puschendorf
Journal:  J Appl Physiol (1985)       Date:  1997-10

6.  Does increased serum creatine kinase activity reflect exercise-induced muscle damage in rats?

Authors:  J Komulainen; T E Takala; V Vihko
Journal:  Int J Sports Med       Date:  1995-04       Impact factor: 3.118

7.  Effects of strenuous exercise on serum myosin heavy chain fragments in male triathletes.

Authors:  E Prou; I Margaritis; F Tessier; J F Marini
Journal:  Int J Sports Med       Date:  1996-05       Impact factor: 3.118

8.  Use of enzyme immunoassay for measurement of skeletal troponin-I utilizing isoform-specific monoclonal antibodies.

Authors:  M Takahashi; L Lee; Q Shi; Y Gawad; G Jackowski
Journal:  Clin Biochem       Date:  1996-08       Impact factor: 3.281

9.  Circulating alpha-actin in angina pectoris.

Authors:  A E Aránega; A Reina; C Velez; L Alvarez; C Melguizo; A Aránega
Journal:  J Mol Cell Cardiol       Date:  1993-01       Impact factor: 5.000

10.  The effect of severe eccentric exercise-induced muscle damage on plasma elastase, glutamine and zinc concentrations.

Authors:  M Gleeson; N P Walsh; A K Blannin; P J Robson; L Cook; A E Donnelly; S H Day
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1998-05
View more
  7 in total

1.  Development aggravates the severity of skeletal muscle catabolism induced by endotoxemia in neonatal pigs.

Authors:  Renán A Orellana; Agus Suryawan; Fiona A Wilson; María C Gazzaneo; Marta L Fiorotto; Hanh V Nguyen; Teresa A Davis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-01-25       Impact factor: 3.619

2.  Immunoglobulin responses to a repeated bout of downhill running.

Authors:  A J McKune; L L Smith; S J Semple; B Mokethwa; A A Wadee
Journal:  Br J Sports Med       Date:  2006-08-18       Impact factor: 13.800

3.  Effect of nuclear factor κB inhibition on serotype 9 adeno-associated viral (AAV9) minidystrophin gene transfer to the mdx mouse.

Authors:  Daniel P Reay; Gabriela A Niizawa; Jon F Watchko; Molly Daood; Ja'Nean C Reay; Eugene Raggi; Paula R Clemens
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

4.  The ACTN3 genotype in soccer players in response to acute eccentric training.

Authors:  Eduardo Mendonça Pimenta; Daniel Barbosa Coelho; Izinara Rosse Cruz; Rodrigo Figueiredo Morandi; Christiano Eduardo Veneroso; Guilherme de Azambuja Pussieldi; Maria Raquel Santos Carvalho; Emerson Silami-Garcia; José Antonio De Paz Fernández
Journal:  Eur J Appl Physiol       Date:  2011-08-13       Impact factor: 3.078

5.  Role of alpha-actin in muscle damage of injured athletes in comparison with traditional markers.

Authors:  Antonio Martínez Amat; Juan Antonio Marchal Corrales; Fernando Rodríguez Serrano; Houria Boulaiz; Jose Carlos Prados Salazar; Fidel Hita Contreras; Octavio Caba Perez; Esmeralda Carrillo Delgado; Ignacio Martín; Antonia Aranega Jimenez
Journal:  Br J Sports Med       Date:  2007-02-22       Impact factor: 13.800

6.  Plasma Actin, Gelsolin and Orosomucoid Levels after Eccentric Exercise.

Authors:  Éva Tékus; Márk Váczi; Zoltán Horváth-Szalai; Andrea Ludány; Tamás Kőszegi; Márta Wilhelm
Journal:  J Hum Kinet       Date:  2017-03-15       Impact factor: 2.193

Review 7.  Stimuli-Responsive Delivery of Growth Factors for Tissue Engineering.

Authors:  Moyuan Qu; Xing Jiang; Xingwu Zhou; Canran Wang; Qingzhi Wu; Li Ren; Jixiang Zhu; Songsong Zhu; Peyton Tebon; Wujin Sun; Ali Khademhosseini
Journal:  Adv Healthc Mater       Date:  2020-03-03       Impact factor: 9.933

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.